Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$89,335,940
-$56,166,319 QoQ
Shares Held
1,572,539
-67.9% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#16
of 317 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Derivatives in TVTX
reported options exposure · as of Jun 30, 2026CallValue
$28,405,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. TVTX ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
This page
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in TVTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,335,940 | 1,572,539 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $28,405,000 | 500,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $89,335,940 | 1,572,539 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $145,502,259 | 4,897,417 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $143,818,275 | 3,763,891 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $160,703,600 | 6,724,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $131,364,800 | 8,876,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $158,986,240 | 8,872,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $128,176,360 | 7,358,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $106,995,520 | 7,648,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $61,650,000 | 7,500,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $57,825,000 | 7,500,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $66,382,160 | 7,384,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $67,050,000 | 7,500,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $114,432,000 | 7,450,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $160,758,520 | 7,148,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $134,844,360 | 6,412,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $143,799,040 | 5,836,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $128,903,600 | 5,320,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $127,767,660 | 4,958,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $126,581,120 | 4,078,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $115,139,000 | 4,748,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $83,863,320 | 5,748,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $58,829,320 | 2,356,000 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||